Press Releases | DEA.gov
Pasar al contenido principal
U.S. flag

Un sitio oficial del Gobierno de Estados Unidos

Así es como usted puede verificarlo

Dot gov
Los sitios web oficiales usan .gov
Un sitio web .gov pertenece a una organización oficial del Gobierno de Estados Unidos.
Https

Los sitios web seguros .gov usan HTTPS
Un candado ( Candado Un candado cerrado ) o https:// significa que usted se conectó de forma segura a un sitio web .gov. Comparta información sensible sólo en sitios web oficiales y seguros.

  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contáctenos
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
      • Fee Waiver
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Recibir Actualizaciones
  • Scam Alert
  • Menú Completo
  • English
  • Español

Main Menu

Explore DEA
  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
    • DEA Museum
    • Wall of Honor
    • Contáctenos
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2025 (1)
  • 2024 (2)
  • 2023 (1)
  • 2022 (6)
  • 2021 (3)
  • 2020 (1)

Subject

  • Drug Trafficking (143)
  • Arrests/Convictions - Major (123)
  • Synthetic drugs (74)
  • Seizures (Drugs/Property) (47)
  • Overdose (46)
  • Guns/Weapons (43)
  • Fake Pills (40)
  • Major Law Enforcement Operation (29)
  • Guilty Plea (27)
  • OCDETF/Task Force (22)
  • Take Back Day (22)
  • Prescription Drugs (19)
  • Outreach/Drug Prevention (17)
  • Extraditions (10)
  • Money Laundering (10)
  • Diversion Division (9)
  • Prevention/Education - DEA websites GSAD, JTT etc (9)
  • Task Forces/Task Force Officers (6)
  • Fentanyl Awareness (5)
  • Press Conferences (4)
  • Public and Media Affairs - also see Congressional Affairs (4)
  • Gangs (3)
  • International/Foreign Operations (3)
  • HIDTA (2)
  • Narcoterrorism (2)
  • One Pill Can Kill (2)
  • Red Ribbon (2)
  • Asset Forfeiture (1)
  • Dark Web- Internet Trafficking (1)
  • El Paso Intelligence Center (1)
  • Intergovernmental Affairs (1)
  • Other (1)
  • Recruitment/Office of Training/Graduations (1)
  • Scam Calls (1)
  • Pharmaceuticals/Pharmacists/Physicians (14)

Field Division

  • Washington, DC (35)
  • St. Louis (32)
  • New York (21)
  • Chicago (19)
  • Miami (16)
  • Atlanta (12)
  • New Jersey (11)
  • Sede (9)
  • Dallas (8)
  • Houston (7)
  • San Francisco (7)
  • Seattle (7)
  • Louisville (5)
  • New England (5)
  • Los Angeles (4)
  • New Orleans (4)
  • Rocky Mountain (3)
  • Omaha (2)
  • Phoenix (2)
  • Philadelphia (1)
  • El Paso (9)
  • San Diego (5)
Clear All Results
PRESS RELEASE

Southern New Mexico Medical Spa Operator Settles Allegations of Controlled-Substance Recordkeeping Violations

Diciembre 03, 2025
Note: View the Settlement Agreement ALBUQUERQUE – The United States has reached a civil settlement with Luis Carlos Cordova, operator of Limitless Aesthetics and Healthcare in Santa Teresa, New Mexico, to resolve allegations that he failed to meet federal controlled-substance recordkeeping requirements under the Controlled Substances Act. According to the...
Diciembre 03, 2025
PRESS RELEASE

OptumRx Agrees to Pay $20M to Resolve Allegations that It Filled Opioid Prescriptions in Violation of the Controlled Substances Act

Junio 27, 2024
SAN DIEGO – OptumRx Inc., a prescription drug benefit provider, has agreed to pay $20 million to resolve allegations that it improperly filled certain opioid prescriptions in violation of the Controlled Substances Act. The settlement resolves an investigation initiated by the Drug Enforcement Administration (DEA) into whether, between April 2013...
Junio 27, 2024
PRESS RELEASE

Palomar Hospital Pays $250,000 for Diverting Fentanyl

Junio 03, 2024
SAN DIEGO – Palomar Health, a California public health care district located in San Diego County, has paid $250,000 to resolve allegations of diversion of fentanyl from one of its facilities and failure to keep accurate records for fentanyl. Palomar Health is California’s largest health care district, with campuses in...
Junio 03, 2024
PRESS RELEASE

Drug Enforcement Administration Announces Fall Take Back Day

Octubre 18, 2023
El Paso, Texas – On Saturday October 28, from 10 a.m. to 2 p.m., the Drug Enforcement Administration and various local agencies will host DEA’s National Prescription Drug Take Back Day at locations across the country. DEA and its partners will collect tablets, capsules, patches, and other solid forms of...
Octubre 18, 2023
PRESS RELEASE

Doctor and Office Manager Indicted in Scheme to Defraud Medicare, Manufacture and Distribute Fentanyl

Diciembre 16, 2022
SAN DIEGO - Dr. David J. Smith, a pain management physician, and his office manager, Julia Ann Oertle, are charged in a federal grand-jury indictment with perpetuating a long-running scheme to commit healthcare fraud and to manufacture and distribute adulterated fentanyl. Smith made his initial appearance today before U.S. Magistrate...
Diciembre 16, 2022
PRESS RELEASE

New Mexico Pharmacy Agrees to Settlement Relating to Violations of the Controlled Substances Act

Julio 12, 2022
ALBUQUERQUE, N.M. – Alexander M.M. Uballez, United States Attorney for the District of New Mexico, announced today that Joe’s Pharmacy of Peralta, New Mexico, has agreed to pay to the United States $50,000 representing civil penalties under the Controlled Substances Act (CSA). The agreement settles civil claims against Joe’s Pharmacy...
Julio 12, 2022
PRESS RELEASE

Former El Paso Physician Agrees to Pay $350,000 to Resolve Allegations

Abril 25, 2022
EL PASO, Texas – Dr. Herbert Nassour, a former physician in El Paso, has agreed to pay $350,000 under a civil settlement to resolve allegations he violated certain provisions of the Controlled Substances Act (CSA). Dr. Nassour was a physician registered with the Drug Enforcement Administration (DEA) to prescribe and...
Abril 25, 2022
PRESS RELEASE

Las Cruces psychiatrist pleads guilty to unlawfully prescribing opioids

Marzo 28, 2022
ALBUQUERQUE, N.M. – Mark Beale, 75, of Las Cruces, New Mexico, pleaded guilty on March 25 in federal court to unlawful dispensing and distributing of a schedule II controlled substance. Beale will remain on conditions of release pending sentencing. A federal grand jury indicted Beale on June 23, 2021. According...
Marzo 28, 2022
PRESS RELEASE

Ready Pharmacy agrees to $400,000 settlement relating to Controlled Substances Act claims

Febrero 01, 2022
ALBUQERQUE, N.M. – Fred J. Federici, U.S. Attorney for the District of New Mexico, has announced that Ready Pharmacy has agreed to a $400,000 settlement relating to civil claims brought by the Department of Justice on behalf of the U.S. Drug Enforcement Administration’s (DEA) El Paso Division Regulatory Diversion Group...
Febrero 01, 2022
PRESS RELEASE

San Diego Pharmacy Pays $105,000 Penalty for Illegitimately Dispensing Opioids

Enero 20, 2022
SAN DIEGO – San Diego’s Balboa Pharmacy has paid $105,000 to resolve allegations that it illegally dispensed opioids and other dangerous drugs to its patients, according to a settlement agreement signed by Balboa Pharmacy and the United States. The settlement stems from the United States’ continued efforts to combat the...
Enero 20, 2022
Showing 1 - 10 of 14 results

Paginación

  • Current page 1
  • Página 2
  • Siguiente página ›
  • Última página »
  • Quienes Somos
    • Sobre
    • Contáctenos
    • Museo DEA
  • Recursos
    • Ley de Libertad de Información (FOIA)
    • Publicaciones
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
  • Políticas
    • Accesibilidad, Complementos y Política
    • Políticas Legales y Descargos de Responsabilidad
    • Antidiscriminación y Represalias Acto
    • Política de Privacidad
    • Política de Igualdad de Oportunidades en el Empleo del U.S. DOJ
    • USA.gov
    • Protección de Denunciantes
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000 info@dea.gov
Contact the Webmaster